Contract facts
FederalPILOT TESTING THE MEDMORPH is a federal award for Cdc Office Of Acquisition Services held by Carradora Health, Inc. Estimated value $2.4M ($1.2M obligated). Current period of performance ends Feb 28, 2026 (potential Aug 31, 2027). Last award drew 2 bidders. Place of performance: ROCKVILLE MD. Related solicitation 75D301-23-Q-76166.
Recompete timing
PublicCurrent PoP ended Feb 28, 2026 (174 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordCarradora Health, Inc — $1.0M obligated across 6 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75D30123F17765?
75D30123F17765 (PILOT testing the medmorph) is a Cdc Office Of Acquisition Services award with a potential value of $2.4M, currently held by Carradora Health, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75D30123F17765?
Cdc Office Of Acquisition Services awarded 75D30123F17765 to Carradora Health, Inc (potential $2.4M).
Who is the incumbent on 75D30123F17765?
Carradora Health, Inc is the incumbent with $1.0M across 6 related awards in SCOUT’s public footprint. The current period of performance ends Feb 28, 2026.
When does Carradora Health, Inc’s 75D30123F17765 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 28, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.